| 1 |
Abacavir
| 4件: Abacavir Abacavir; Abacavir sulfate; Triumeq; Ziagen | 2件: D00891
D00891
,
D07057
| - | - | 4件: 2 2, 135, 265, 325 |
| 2 |
Baricitinib
| 2件: Baricitinib Baricitinib; Olumiant | 1件: D10308
D10308
| 2件: JAK1 JAK1,
JAK2 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 13件: 41 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325 |
| 3 |
Emtricitabine
| 2件: Emtricitabine Emtricitabine; TRUVADA | 1件: D01199
D01199
| - | - | 4件: 25 25, 93, 265, 325 |
| 4 |
Lamivudine
| 4件: COMBIVIR COMBIVIR; Epivir; Lamivudine; Triumeq | 1件: D00353
D00353
| - | - | 7件: 2 2, 26, 42, 46, 135, 265, 325 |
| 5 |
Tenofovir
| 1件: Tenofovir Tenofovir | 1件: D06074
D06074
| - | - | 6件: 2 2, 13, 25, 93, 265, 325 |
| 6 |
Zidovudine
| 3件: COMBIVIR COMBIVIR; Retrovir; Zidovudine | 1件: D00413
D00413
| - | - | 7件: 25 25, 26, 94, 135, 265, 325, 331 |